Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
08 2019
Historique:
received: 23 01 2019
revised: 01 04 2019
accepted: 01 04 2019
pubmed: 18 4 2019
medline: 13 3 2020
entrez: 18 4 2019
Statut: ppublish

Résumé

The optimal duration of postsurgical antibiotic therapy for adult native joint bacterial arthritis remains unknown. We conducted a prospective, unblinded, randomised, non-inferiority study comparing either 2 or 4 weeks of antibiotic therapy after surgical drainage of native joint bacterial arthritis in adults. Excluded were implant-related infections, episodes without surgical lavage and episodes with a follow-up of less than 2 months. We enrolled 154 cases: 77 in the 4-week arm and 77 in the 2-week arm. Median length of intravenous antibiotic treatment was 1 and 2 days, respectively. The median number of surgical lavages was 1 in both arms. Recurrence of infection was noted in three patients (2%): 1 in the 2-week arm (99% cure rate) and 2 in the 4-week arm (97% cure rate). There was no difference in the number of adverse events or sequelae between the study arms. Of the overall 154 arthritis cases, 99 concerned the hand and wrist, for which an additional subgroup analysis was performed. In this per-protocol subanalysis, we noted three recurrences: one in the 2-week arm (97 % cure); two in the 4-week arm (96 % cure) and witnessed sequelae in 50% in the 2-week arm versus 55% in the 4-week arm, of which five (13%) and six (13%) needed further interventions. After initial surgical lavage for septic arthritis, 2 weeks of targeted antibiotic therapy is not inferior to 4 weeks regarding cure rate, adverse events or sequelae and leads to a significantly shorter hospital stay, at least for hand and wrist arthritis. NCT03615781.

Identifiants

pubmed: 30992295
pii: annrheumdis-2019-215116
doi: 10.1136/annrheumdis-2019-215116
pmc: PMC6691865
doi:

Substances chimiques

Anti-Bacterial Agents 0

Banques de données

ClinicalTrials.gov
['NCT03615781']

Types de publication

Comparative Study Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1114-1121

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Pediatr Orthop. 2000 Jan-Feb;20(1):44-7
pubmed: 10641687
J Pediatr Orthop. 2002 May-Jun;22(3):317-20
pubmed: 11961446
Arch Orthop Trauma Surg. 2002 May;122(4):204-11
pubmed: 12029509
Clin Infect Dis. 2003 Feb 1;36(3):319-27
pubmed: 12539074
Best Pract Res Clin Rheumatol. 2003 Apr;17(2):183-200
pubmed: 12787520
Clin Med (Lond). 2004 Nov-Dec;4(6):510-8
pubmed: 15656476
Int J Infect Dis. 2005 May;9(3):127-38
pubmed: 15840453
Rev Chilena Infectol. 2008 Feb;25(1):30-6
pubmed: 18273522
J Infect. 2009 Mar;58(3):205-12
pubmed: 19232739
Clin Infect Dis. 2009 May 1;48(9):1201-10
pubmed: 19323633
J Pediatr Orthop. 2009 Sep;29(6):636-42
pubmed: 19700997
Int Orthop. 2011 May;35(5):647-54
pubmed: 20419507
Infection. 2010 Oct;38(5):407-12
pubmed: 20508966
J Hosp Infect. 2012 Sep;82(1):40-8
pubmed: 22738613
Int J Infect Dis. 2013 Mar;17(3):e199-205
pubmed: 23183231
J Hosp Infect. 2013 May;84(1):5-12
pubmed: 23414705
J Infect. 2013 Nov;67(5):433-8
pubmed: 23850617
Int Orthop. 2014 Jun;38(6):1283-90
pubmed: 24496757
J Plast Reconstr Aesthet Surg. 2014 Oct;67(10):1451-2
pubmed: 24912745
Lancet. 2015 Mar 7;385(9971):875-82
pubmed: 25468170
Chir Main. 2015 Feb;34(1):18-23
pubmed: 25579828
Infect Dis (Lond). 2015 Apr;47(4):252-4
pubmed: 25622939
Infect Dis (Lond). 2015;47(10):747-8
pubmed: 25990679
Int J Infect Dis. 2015 Nov;40:81-91
pubmed: 26460089
Open Forum Infect Dis. 2017 Mar 25;4(2):ofx058
pubmed: 28491895
Lancet. 1988 Jan 2-9;1(8575-6):37-40
pubmed: 2891899
Rev Med Suisse. 2018 Mar 7;14(597):516-521
pubmed: 29512948
J Infect. 2018 Jul;77(1):47-53
pubmed: 29742468
N Engl J Med. 2019 Jan 31;380(5):425-436
pubmed: 30699315
Anesthesiology. 1978 Oct;49(4):239-43
pubmed: 697077

Auteurs

Ergys Gjika (E)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Jean-Yves Beaulieu (JY)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Konstantinos Vakalopoulos (K)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Morgan Gauthier (M)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Cindy Bouvet (C)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Amanda Gonzalez (A)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Vanessa Morello (V)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Christina Steiger (C)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Stefanie Hirsiger (S)

Hand Surgery Unit, Hopitaux Universitaires de Geneve, Geneva, Switzerland.

Benjamin Alan Lipsky (BA)

Service of Infectious Diseases, Hopitaux Universitaires de Geneve, Geneva, Switzerland.
Division of Medical Sciences, University of Oxford, Oxford, UK.

Ilker Uçkay (I)

Service of Infectious Diseases, Hopitaux Universitaires de Geneve, Geneva, Switzerland ilker.uckay@balgrist.ch.
Uniklinik Balgrist, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH